![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, . 2004. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism 89:453–462.
- Azziz R. 2006. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. Journal of Clinical Endocrinology and Metabolism 91:781–785.
- Azziz R. 2008. Diagnosing the diagnosis: why we must standardise the defining features of polycystic ovarian syndrome. Annals of Clinical Biochemistry 45:3–5.
- Barth JH, Yasmin E, Balen AH. 2007. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clinical Endocrinology 67: 811–815.
- Beckman Coulter. 2007. Testosterone immunoassay user manual; Reference 33560. Watford: Beckman Coulter.
- Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, . 2005. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clinical Chemistry 51:1472–1479.
- Dennedy MC, Smith D, O'Shea D, McKenna TJ. 2010. Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma. European Journal of Endocrinology 162:213–220.
- Erhmann DA. 2005. Polycystic ovary syndrome. New England Journal of Medicine 352:1223–1236.
- Fauser and Co-workers for the Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41–47.
- Hollis S. 1996. Analysis of method comparison studies. Annals of Clinical Biochemistry 33:1–4.
- Kane J, Middle J, Cawood M. 2007. Measurement of serum testosterone on women; what should we do? Annals of Clinical Biochemistry 44:5–15.
- Legro RS, Kunselman AR, Dunaif A. 2007. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. American Journal of Medicine 111:607–613.
- Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, Brzyski RG .; Reproductive Medicine Network. 2010. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. Journal of Clinical Endocrinology and Metabolism 95: 5305–5313.
- Norman RJ, Dewailly D, Legro RS, Hickey TE. 2007. Polycystic ovary syndrome. Lancet 370:685–697.
- Pasquali R, Gambineri A. 2006. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Annals of the New York Academy of Sciences 1092:158–174.
- Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. 2007. Position statement: Utility limitations and pitfalls in measuring testosterone: An Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 92:405–413.
- Stanczyk FZ. 2006. Diagnosis of hyperandrogenism: biochemical criteria. Best Practice and Research Clinical Endocrinology and Metabolism 20:177–191.
- Stenman UH. 2004. Standardization of assays for human chorionic gonadotropin. Clinical Chemistry 50:798–800.
- Villarroel C, Trejo L, Muñoz A, Kohen P, Fuentes A, Devoto L. 2010. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves. Gynecological Endocrinology 26:600–606.